Literature DB >> 14962946

Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.

Sabine M Post1, Martine Groenendijk, Karianne Solaas, Patrick C N Rensen, Hans M G Princen.   

Abstract

OBJECTIVE: Cholesterol 7alpha-hydroxylase (cyp7a1) catalyzes the rate-limiting step in conversion of cholesterol to bile acids. To study the relationship between bile acid biosynthesis and triglyceride metabolism, we cross-bred mice lacking cyp7a1 on a hyperlipidemic APOE*3-Leiden background. METHODS AND
RESULTS: Female mice received a chow or lipogenic diet. On both diets, fecal bile acid excretion was 70% decreased concomitantly with a 2-fold increased neutral sterol output. The differences in bile acid biosynthesis did not change plasma cholesterol levels. However, plasma triglyceride levels decreased by 41% and 38% in the cyp7a1-/-. APOE*3-Leiden mice as compared with APOE*3-Leiden mice on chow and lipogenic diet, respectively. Mechanistic studies showed that very-low-density lipoprotein (VLDL)-apolipoprotein B and VLDL-triglyceride production rates were reduced in cyp7a1-/-. APOE*3-Leiden mice as compared with APOE*3-Leiden mice (-34% and -35%, respectively). Cyp7a1 deficiency also increased the hepatic cholesteryl ester and triglyceride content (2.8-fold and 2.5-fold, respectively). In addition, hepatic anti-oxidative vitamin content, which can influence VLDL-production, was lower. Hepatic mRNA analysis showed decreased expression of genes involved in lipogenesis including srebf1.
CONCLUSIONS: Cyp7a1 deficiency in APOE*3-Leiden mice decreases the VLDL particle production rate, as a consequence of a strongly reduced bile acid biosynthesis, leading to a decrease in plasma triglycerides. These data underscore the close relationship between bile acid biosynthesis and triglyceride levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962946     DOI: 10.1161/01.ATV.0000121572.21122.59

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.

Authors:  Jian Shen; Donna K Arnett; Laurence D Parnell; Chao-Qiang Lai; Robert J Straka; Paul N Hopkins; Ping An; Mary F Feitosa; José M Ordovás
Journal:  J Cardiovasc Pharmacol       Date:  2012-03       Impact factor: 3.105

2.  Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.

Authors:  Jean Z Lin; Alexandro J Martagón; Willa A Hsueh; John D Baxter; Jan-Åke Gustafsson; Paul Webb; Kevin J Phillips
Journal:  Endocrinology       Date:  2012-10-19       Impact factor: 4.736

3.  Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis.

Authors:  Yanyong Xu; Yang Xu; Yingdong Zhu; Huihui Sun; Cody Juguilon; Feng Li; Daping Fan; Liya Yin; Yanqiao Zhang
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

4.  Maternal protein restriction induces alterations in hepatic tumor necrosis factor-α/CYP7A1 signaling and disorders regulation of cholesterol metabolism in the adult rat offspring.

Authors:  Xiaomei Liu; Ying Qi; Baoling Tian; Dong Chen; Hong Gao; Chunyan Xi; Yanlin Xing; Zhengwei Yuan
Journal:  J Clin Biochem Nutr       Date:  2014-05-13       Impact factor: 3.114

5.  Association between dietary intake and postlaparoscopic cholecystectomic symptoms in patients with gallbladder disease.

Authors:  Yongju Shin; Dongho Choi; Kyeong Geun Lee; Ho Soon Choi; Yongsoon Park
Journal:  Korean J Intern Med       Date:  2017-11-10       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.